Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The use of the Klopman index as a new descriptor for pharmacophore analysis on strong aromatase inhibitor flavonoids against estrogen-dependent breast cancer


We present the Klopman index, which is effective in explaining the mechanisms of organic chemistry, in quantitative structure activity relationship (QSAR) studies on flavonoids as a new descriptor for the first time. Instead of using random descriptors to elucidate the interactions between the ligand and the receptor, the atomic local reactive descriptor (LRD) which we call as the Klopman index in our molecular conformer electron topological (MCET) program was used. Both the atomic charges and the frontier orbital coefficients are used simultaneously in the Klopman index. Substrate-aromatase interactions of strong aromatase inhibitors against estrogen-dependent breast cancer were investigated by the pharmacophore model (PhaM) defined using MCET. All the conformers in the series were aligned with the template to match with the enzyme in three dimensional (3D). The parameters of the enzyme at the interaction points were determined according to the descriptor of the molecules in the training set. Contour maps of enzyme parameters show the interaction points of aromatase with the flavonoid group used in this study. Traditional validation parameters (Q2 = 0.883 and R2pred = 0.895) were supported by a more stringent validation (a new parameter R2m-overall = 0.6).

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2


  1. 1.

    Brodie AMH, Njar VCO (1998) Aromatase inhibitors in advanced breast cancer: mechanism of action and clinical implications. J Steroid Biochem 66(1–2):1–10

  2. 2.

    Brueggemeier RW, Hackett JC, Diaz-Cruz ES (2005) Aromatase inhibitors in the treatment of breast cancer. Endocr Rev 26(3):331–345

  3. 3.

    Liu MM, Huang Y, Wang J (2012) Developing phytoestrogens for breast Cancer prevention. Anti-Cancer Agent Me 12(10):1306–1313

  4. 4.

    Pelissero C, Lenczowski MJP, Chinzi D, DavailCuisset B, Sumpter JP, Fostier A (1996) Effects of flavonoids on aromatase activity, an in vitro study. J Steroid Biochem 57(3–4):215–223

  5. 5.

    Whitehead SA, Lacey M (2003) Phytoestrogens inhibit aromatase but not 17 beta-hydroxysteroid dehydrogenase (HSD) type 1 in human granulosa-luteal cells: evidence for FSH induction of 17 beta-HSD. Hum Reprod 18(3):487–494

  6. 6.

    Monteiro R, Becker H, Azevedo I, Calhau C (2006) Effect of hop (Humulus lupulus L.) flavonoids on aromatase (estrogen synthase) activity. J Agr Food Chem 54(8):2938–2943

  7. 7.

    Nantasenamat C, Isarankura-Na-Ayudhya C, Naenna T, Prachayasittikul V (2009) A practical overview of quantitative structure-activity relationship. EXCLI J 8:74–88

  8. 8.

    Nantasenamat C, Isarankura-Na-Ayudhya C, Prachayasittikul V (2010) Advances in computational methods to predict the biological activity of compounds. Expert Opin Drug Dis 5(7):633–654

  9. 9.

    Wilson GL, Lill MA (2011) Integrating structure-based and ligand-based approaches for computational drug design. Future Med Chem 3(6):735–750

  10. 10.

    Narayana BL, Kishore DP, Balakumar C, Rao KV, Kaur R, Rao AR, Murthy JN, Ravikumar M (2012) Molecular modeling evaluation of non-steroidal aromatase inhibitors. Chem Biol Drug Des 79(5):674–682

  11. 11.

    Cramer RD, Patterson DE, Bunce JD (1988) Comparative Molecular-Field Analysis (Comfa) .1. Effect of Shape on Binding of Steroids to Carrier Proteins. J Am Chem Soc 110(18):5959–5967

  12. 12.

    Türkmenoğlu B, Yılmaz H, Su EM, Alp Tokat T, Güzel Y (2017) 4D-QSAR study of flavonoid derivatives with MCET method. Int J Chem Technol 1:14–23

  13. 13.

    Yilmaz H, Boz M, Turkmenoglu B, Guzel Y (2014) Pharmacophore and functional group identification of 4,4 '-dihydroxydiphenylmethane as Bisphenol-a (BSA) derivative. Trop J Pharm Res 13(1):117–126

  14. 14.

    Balunas MJ, Su B, Brueggemeier RW, Kinghorn AD (2008) Natural products as aromatase inhibitors. Anti-Cancer Agent Me 8(6):646–682

  15. 15.

    Su EM, Turkmenoglu B, Guzel Y (2016) 3D biostructure visualisation using 4D-QSAR model for substitute Ureas binding at the Raf-1 kinase receptor site. Int J Innov Stud Sci Eng Technol 02(12):67–75

  16. 16.

    Guzel Y, Aslan E, Turkmenoglu B, Su EM (2018) 4D-QSAR studies using a new descriptor of the Klopman index: antibacterial activities of Sulfone derivatives containing 1, 3, 4-Oxadiazole moiety based on MCET model. Curr Comput-Aid Drug 14(3):207–220

  17. 17.

    Turkmenoglu B, Guzel Y (2018) Molecular docking and 4D-QSAR studies of metastatic cancer inhibitor thiazoles. Comput Biol Chem 76:327–337

  18. 18.

    Alp Tokat T (2019) Türkmenoğlu, B., Kızılcan, D. Ş., Güzel, Y.: investigation of 3D pharmacophore of N-benzyl benzamide molecules of melanogenesis inhibitors using a new descriptor Klopman index: uncertainties in model. J Mol Model 25(247):1–13

  19. 19.

    LoPachin RM, Barber DS, Gavin T (2008) Molecular mechanisms of the conjugated alpha,beta-unsaturated carbonyl derivatives: Relevance to neurotoxicity and neurodegenerative diseases. Toxicol Sci 104(2):235–249

  20. 20.

    Pearson RG (1990) Hard and soft acids and bases - the evolution of a chemical concept. Coordin Chem Rev 100:403–425

  21. 21.

    LoPachin RM, Geohagen BC, Gavin T (2009) Synaptosomal toxicity and Nucleophilic targets of 4-Hydroxy-2-Nonenal. Toxicol Sci 107(1):171–181

  22. 22.

    Awasthi M, Singh S, Pandey VP, Dwivedi UN (2015) Molecular docking and 3D-QSAR-based virtual screening of flavonoids as potential aromatase inhibitors against estrogen-dependent breast cancer. J Biomol Struct Dyn 33(4):804–819

  23. 23.

    Martin YC, Bures MG, Danaher EA, Delazzer J, Lico I, Pavlik PA (1993) A fast new approach to Pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists. J Comput Aid Mol Des 7(1):83–102

  24. 24.

    Brint AT, Willett P (1987) Algorithms for the identification of 3-dimensional maximal common substructures. J Chem Inf Comp Sci 27(4):152–158

  25. 25.

    Crippen GM (1981) Quantitative structure-activity-relationships by distance geometry - Thyroxine binding-site. J Med Chem 24(2):198–203

  26. 26.

    Cohen CN (1996) Guidebook on molecular modeling in drug design. Academic Press, Boston

  27. 27.

    Noorizadeh H, Farmany A (2010) Exploration of linear and nonlinear modeling techniques to predict of retention index of essential oils. J Chin Chem Soc-Taip 57(6B):1268–1277

  28. 28.

    Klopman G (1968) Chemical reactivity and the concept of charge- and frontier-controlled reactions. J Am Chem Soc 90(2):223–243

  29. 29.

    Salem L (1968) Intermolecular orbital theory of the interaction between conjugated systems. I. General theory. J Am Chem Soc 90(3):543–552

  30. 30.

    Reed AE, Curtiss LA, Weinhold F (1988) Intermolecular interactions from a natural bond orbital, Donor-Acceptor Viewpoint. Chem Rev 88(6):899–926

  31. 31.

    Takemoto Y (2005) Recognition and activation by ureas and thioureas: stereoselective reactions using ureas and thioureas as hydrogen-bonding donors. Org Biomol Chem 3(24):4299–4306

  32. 32.

    Wittkopp A, Schreiner PR (2003) Metal-free, noncovalent catalysis of Diels-Alder reactions by neutral hydrogen bond donors in organic solvents and in water. Chem-Eur J 9(2):407–414

Download references


This work was financially supported by Erciyes University Scientific Research Projects (BAP) of Turkey (Grant no. FDK-2016-6547).

Author information

Correspondence to Yahya Güzel.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kızılcan, D.Ş., Türkmenoğlu, B. & Güzel, Y. The use of the Klopman index as a new descriptor for pharmacophore analysis on strong aromatase inhibitor flavonoids against estrogen-dependent breast cancer. Struct Chem (2020).

Download citation


  • Flavonoid derivatives
  • 4D-QSAR
  • MCET
  • Pharmacophore